Treatment of pustulosis palmaris et plantaris with oral doses of colchicine.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 7092269)

Published in Arch Dermatol on July 01, 1982

Authors

M Takigawa, Y Miyachi, M Uehara, H Tagami

Articles by these authors

TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18

Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol (1999) 2.77

Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (1999) 2.18

Chromatin boundaries and chromatin domains. Cold Spring Harb Symp Quant Biol (2004) 2.08

Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98

Levels of cyclic-AMP, cyclic-GMP and betamethasone in the aqueous humor following topical administration of betamethasone in rabbit eyes. Hiroshima J Med Sci (1983) 1.89

Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene. Biochem Biophys Res Commun (1989) 1.85

Leukotactic properties of soluble substances in psoriasis scale. Br J Dermatol (1976) 1.68

Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars. Arch Dermatol (1996) 1.62

Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61

Non-pigmented nodular plantar melanoma in 12 Japanese patients. Br J Dermatol (1997) 1.60

Molecular basis for the heterogeneity of human tyrosinase. Tohoku J Exp Med (1988) 1.58

Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice. J Invest Dermatol (1996) 1.57

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut (1987) 1.57

Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology (2000) 1.57

p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity. Oncogene (2007) 1.56

Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol (2000) 1.54

Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin Exp Allergy (1998) 1.54

Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology (2000) 1.52

Cloning of the Membrane-Bound Aldehyde Dehydrogenase Gene of Acetobacter polyoxogenes and Improvement of Acetic Acid Production by Use of the Cloned Gene. Appl Environ Microbiol (1989) 1.52

Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol (2000) 1.51

A long-term follow-up study of diabetic patients in Osaka, Japan: mortality and causes of death. Tohoku J Exp Med (1983) 1.50

A global repressor (Mlc) is involved in glucose induction of the ptsG gene encoding major glucose transporter in Escherichia coli. Mol Microbiol (1998) 1.49

Human ACTH hypersensitivity syndrome associated with abnormalities of the ACTH receptor gene. Clin Endocrinol (Oxf) (1998) 1.43

Unilateral dermatomal pigmentary dermatosis: a variant dyschromatosis? J Am Acad Dermatol (1992) 1.42

Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells. Am J Transplant (2015) 1.41

Eosinophilic pustular folliculitis starting initially only with palmoplantar pustular lesions. Report of a case and review of the literature. Dermatology (1992) 1.40

Gender of demented patients and specific family relationship of caregiver to patients influence mental fatigue and burdens on relatives as caregivers. Int J Geriatr Psychiatry (1999) 1.40

Immunohistochemically detectable duct-like structures in benign and malignant eccrine poromas: CEA and involucrin immunostaining. J Dermatol (1989) 1.39

I-123 iomazenil SPECT in patients with mental disorders. Ann Nucl Med (1997) 1.39

Three major coronary artery-to-left ventricular shunts: report of three cases and review of literature. Cardiovasc Intervent Radiol (1997) 1.39

Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch Dermatol (1986) 1.39

Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol (1986) 1.38

Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol (2000) 1.38

Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Commun (1997) 1.37

Chronic vulvar purpura. Dermatologica (1990) 1.37

Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol (1997) 1.37

Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology (2004) 1.34

Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res (1997) 1.33

Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology (2001) 1.30

Sequence of events during germination of putrefactive anaerobe 3679 spores. J Bacteriol (1967) 1.27

What is the 'true' function of skin? Exp Dermatol (2002) 1.26

What is the physiological function of mast cells? Exp Dermatol (2003) 1.26

Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J (2001) 1.25

Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol (1998) 1.24

Number of cell layers of the stratum corneum in normal skin - relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res (1999) 1.24

Random amplification of polymorphic DNA is useful for the differentiation of several anthropophilic dermatophytes. Mycoses (1997) 1.24

Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol (1996) 1.23

Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci Lett (1999) 1.23

Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol (1998) 1.23

E- and P-cadherin expression during murine hair follicle morphogenesis and cycling. Exp Dermatol (1999) 1.22

Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol (2005) 1.21

CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem (2001) 1.21

The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol (1999) 1.20

Immunohistologic studies in Schamberg's disease. Evidence for cellular immune reaction in lesional skin. Arch Dermatol (1988) 1.19

Expression of connective tissue growth factor in cartilaginous tumors. Cancer (2000) 1.19

Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg (2000) 1.17

Negative regulation of the pts operon by Mlc: mechanism underlying glucose induction in Escherichia coli. Genes Cells (1999) 1.17

Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol (2001) 1.17

Analysis of the human intestinal microbiota from 92 volunteers after ingestion of identical meals. Benef Microbes (2013) 1.16

Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism. Biochem Biophys Res Commun (2001) 1.15

Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem (1998) 1.14

Characterization of a leukotactic factor derived from psoriatic scale. Br J Dermatol (1977) 1.14

Papuloerythroderma. Dermatologica (1984) 1.14

Tuberculosis verrucosa cutis in a tumour-like form. Br J Dermatol (1991) 1.14

An evaluation of semen processing methods for eliminating HIV-1. AIDS (2000) 1.13

Regression of plane warts following spontaneous inflammation. An histopathological study. Br J Dermatol (1974) 1.13

Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. J Biochem (1999) 1.13

Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells. J Immunol (2001) 1.12

Cystic lymphangioma arising in the tip of the tongue in an adult. Int J Oral Maxillofac Surg (2005) 1.12

Effect of DL-alpha-hydrazino-delta-aminovaleric acid, an inhibitor of ornithine decarboxylase, on polyamine metabolism in isoproterenol-stimulated mouse parotid glands. J Biochem (1975) 1.12

The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol (1999) 1.10

Histological diagnostic criteria for accessory tragi. J Cutan Pathol (1990) 1.10

Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem (1998) 1.09

Effect of cyclosporin A on the membrane-associated events in human leukocytes with special reference to the similarity with dexamethasone. Biochem Pharmacol (1986) 1.09

Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol (1990) 1.09

Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun (1998) 1.08

Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol (1999) 1.08

Evaluation of the skin surface hydration in vivo by electrical measurement. J Invest Dermatol (1980) 1.08

Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol (1992) 1.07

Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Front Med Biol Eng (1997) 1.06

Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur J Immunol (1996) 1.06

Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp Dermatol (2000) 1.06

Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr (2001) 1.06

Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett (2001) 1.06

Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem Biophys Res Commun (1998) 1.06

Eosinophilic pustular folliculitis. Acta Derm Venereol (1970) 1.06

Role of stimulated neutrophils from patients with systemic lupus erythematosus in tissue injury, with special reference to serum factors and increased active oxygen species generated by neutrophils. Inflammation (1985) 1.05

Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59. J Biol Chem (1990) 1.05

Assessment of growth potential by MIB-1 immunohistochemistry in ameloblastic fibroma and related lesions of the jaws compared with ameloblastic fibrosarcoma. J Oral Pathol Med (1998) 1.05

Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res Dev Brain Res (1997) 1.05

Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3'-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene (2006) 1.05

The Langerhans cell granule is an adsorptive endocytic organelle. J Invest Dermatol (1985) 1.04

Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci U S A (2000) 1.04

Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: cross-sectional and longitudinal studies. Life Sci (1989) 1.04

Conformation dependence of integrin-type II collagen binding. Inability of collagen peptides to support alpha 2 beta 1 binding, and mediation of adhesion to denatured collagen by a novel alpha 5 beta 1-fibronectin bridge. J Cell Sci (1994) 1.04

Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.03

Demonstration of C3 cleavage product in leukotactic substances of scale extract from pustular psoriasis. Br J Dermatol (1977) 1.03